RGH-1756, a new potential atypical antipsychotic:: Anatomical mapping of potential targets

被引：0
|
作者：
Laszlovszky, I
Kovács, KJ
Csejtei, M
机构：
[1] Gedeon Richter Ltd, Pharmacol Res Ctr, H-1475 Budapest 10, Hungary
[2] Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P35122
引用
收藏
页码：R58 / R58
页数：1
相关论文
共 50 条
  • [31] New substituted benzamides with potential antipsychotic action
    Ilie, Corina
    Guta, Rodica
    Nanau-Andreescu, Doina
    Nuta, Diana
    Caproiu, Miron Teodor
    REVISTA DE CHIMIE, 2006, 57 (08): : 845 - 849
  • [32] Experimental pharmacokinetics and metabolism of a new potential antipsychotic
    Boyko, S. S.
    Zherdev, V. P.
    Ostrovskaya, R. U.
    Gudasheva, T. A.
    Mesonznic, N. V.
    Bastrygin, D. V.
    Ivannikova, E. V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S134 - S135
  • [33] Potential atypical antipsychotic agents with with reduced liability for treatment emergent weight gain
    Thompson, L. K.
    Evans, D. C.
    Falcone, J. F.
    Bymaster, F. P.
    Schaus, J. M.
    Martin, F.
    Tupper, D.
    Owton, W.
    Rocco, V. P.
    Pineiro-Nunez, M.
    Chen, Z.
    Yang, Y.
    Rasmussen, K.
    Hemrick-Luecke, S. K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S138 - S138
  • [34] OLANZAPINE - A POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENT - PHASE-II CLINICAL FINDINGS
    HARRISON, DA
    SATTERLEE, W
    TRAN, P
    BEASLEY, CM
    TOLLEFSON, GD
    SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 107 - 107
  • [35] RGH-188, potential antipsychotic with D3/D2 antagonist/partial agonist properties, exhibits an atypical antipsychotic profile in rats with respect to effect oil spontaneously active dopamine neurons
    Adham-Parangi, N.
    Kiss, B.
    Gyertyan, I.
    Gupta, S.
    Szombathelyi, Z.
    Ashby, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 263 - 263
  • [36] Potential risks of adjunctive use of atypical antipsychotic drugs for the treatment of depression Reply
    Nakajima, Shinichiro
    Suzuki, Takefumi
    Watanabe, Koichiro
    Kashima, Haruo
    Uchida, Hiroyuki
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (02): : 435 - 436
  • [37] Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications
    Setoguchi, Soko
    Wang, Philip S.
    Brookhart, M. Alan
    Canning, Claire F.
    Kaci, Liljana
    Schneeweiss, Sebastian
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (09) : 1644 - 1650
  • [38] Synthesis and Computational Studies on Aryloxypropyl Piperazine Derivatives as Potential Atypical Antipsychotic Agents
    Bali, Alka
    Bhalla, Abhishek
    Bala, Suman
    Kumar, Rajesh
    LETTERS IN DRUG DESIGN & DISCOVERY, 2012, 9 (02) : 218 - 224
  • [39] Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931
    Kuriyama, M
    Hashimoto, K
    Morimoto, T
    Tanaka, H
    Fujimura, M
    Kimura, K
    Takehara, S
    Yasumatsu, H
    Yamagami, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S107 - S108
  • [40] Potential new targets for antithrombotic therapy
    Gruber, A
    Hanson, SR
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (28) : 2367 - 2374
12345